High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations is a research paper published in Journal of Antimicrobial Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AI-49170
Canadian Institutes of Health Research
Grant: 377790
CIHR
Grant: BC-370929
Government of Canada through Genome Canada and the Ontario Genomics Institute
Grant: OGI-131
Queen Elizabeth II Diamond Jubilee scholarship
Grant: DLI O19375892122
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01AI049170-12
Impact of HIV-1 fitness on disease progression
NIAID NIH HHS
Grant: R21 AI049170
NIAID NIH HHS
Grant: R56 AI049170
NIAID NIH HHS
Grant: R01 AI049170
NIAID NIH HHS
Grant: P30 AI036219
FWCI
0.77
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals